60 mg, prolonged-release hard capsules, Isosorbide mononitrate
Olicard 60 retard comes in the form of white, opaque, prolonged-release hard capsules containing sugar pellets.
Olicard 60 retard belongs to the pharmacotherapeutic group: vasodilators in cardiac diseases; nitrates.
Indications for use:
Olicard 60 retard is used to prevent angina pectoris attacks in stable coronary artery disease.
Do not take Olicard 60 retard in the following cases:
During treatment with Olicard 60 retard, do not take medicines intended for the treatment of erectile dysfunction, containing as an active substance a 5-phosphodiesterase inhibitor, i.e., sildenafil, vardenafil, or tadalafil, as this may cause a significant decrease in blood pressure.
Before starting treatment with Olicard 60 retard, discuss it with your doctor or pharmacist.
Olicard 60 retard is not intended for the treatment of acute heart pain (e.g., acute angina pectoris) and acute myocardial infarction.
Caution should be exercised when taking Olicard 60 retard in the following cases:
Treatment with Olicard 60 retard may cause transient hypoxia and myocardial ischemia in patients with coronary artery disease.
Consult your doctor, even if the above warnings refer to situations that have occurred in the past.
Tell your doctor about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
An enhancement of the blood pressure-lowering effect occurs with the use of:
Olicard 60 retard used concomitantly with dihydroergotamine may increase its blood levels and thus enhance its blood pressure-increasing effect.
Concomitant use of this medicine with alcohol may cause excessive lowering of blood pressure.
Due to the lack of data on the use of the medicine in pregnant women and the need for special caution in their case, Olicard 60 retard can be taken during pregnancy only on the explicit recommendation of the attending physician. Animal studies do not indicate any direct or indirect harmful effects on pregnancy, embryonic/fetal development, childbirth, or postnatal development at doses corresponding to those used in humans.
During breastfeeding, Olicard 60 retard can be used only on the explicit recommendation of the physician, as it is not known whether the medicine passes into breast milk.
During treatment with Olicard 60 retard, especially at the beginning of treatment, when increasing the dose of the medicine, when switching to another product, and when consuming alcohol, dizziness, drowsiness, or fatigue may occur. This should be taken into account when considering driving a vehicle or operating machinery.
If you have been diagnosed with intolerance to some sugars, you should contact your doctor before taking the medicine.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
Take the medicine orally.
Unless your doctor has told you otherwise:
Take 1 capsule of Olicard 60 retard once a day (which corresponds to taking 60 mg of isosorbide mononitrate).
Treatment should be started with low doses of the medicine, gradually increasing them to achieve the desired dose.
Swallow the prolonged-release hard capsules whole, with a sufficient amount of liquid (e.g., a glass of water).
The duration of treatment is determined by the attending physician.
If you feel that the effect of Olicard 60 retard is too strong or too weak, you should immediately consult your doctor or pharmacist.
If you have taken a higher dose of Olicard 60 retard than recommended, you should immediately consult your doctor or pharmacist.
Since no cases of overdose with Olicard 60 retard have been reported so far, only possible symptoms related to overdose of the medicine can be described.
Depending on the degree of overdose, a significant decrease in blood pressure (hypotension) with an increase in heart rate, headache, fatigue, dizziness, and a feeling of fainting, hot flashes, nausea, vomiting, and diarrhea may occur.
Do not take a double dose to make up for a missed dose.
Continue treatment according to the recommended schedule.
The effectiveness of the treatment may be reduced.
Like all medicines, Olicard 60 retard can cause side effects, although not everybody gets them.
The most commonly observed side effect is headache, which gradually decreases during continued treatment.
Very common (occurred in at least 1 in 10 patients) side effects include:
Common (occurs in 1 to 10 in 100 patients) side effects include:
Uncommon (occurs in 1 to 10 in 1,000 patients) side effects include:
The following side effects have been reported with a frequency that cannot be estimated from the available data:
Other instructions:
After administration of Olicard 60 retard, transient hypoxia may occur in the arterial blood due to the displacement of blood to less well-ventilated areas of the lungs.
In patients with coronary artery disease, this may lead to inadequate oxygen supply to the heart muscle.
Ineffectiveness and reduced efficacy of the medicine have been reported in cases of prior use of nitrates. To avoid weakening or loss of the medicine's effect, continuous administration of the preparation in high doses should be avoided.
After the first symptoms of hypersensitivity to Olicard 60 retard appear, the use of the medicine should be discontinued.
In the event of any of the above side effects, you should inform your doctor, who will assess the severity of the complications and decide on the need for further preventive measures.
In some individuals, other side effects may occur during treatment with the medicine. If other side effects occur that are not listed in this leaflet, you should inform your doctor.
If you experience any side effects, including any not listed in the leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301; fax: +48 22 49 21 309; website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of the medicine.
Keep the medicine out of the sight and reach of children.
Store in the original package, at a temperature below 25°C.
Do not use this medicine after the expiry date stated on the package after: Expiry date. The expiry date refers to the last day of the month stated.
Olicard 60 retard comes in the form of prolonged-release hard capsules, packaged in blisters of 20 or 50 pieces in a cardboard box.
Not all pack sizes may be marketed.
Viatris Healthcare Sp. z o.o.
ul. Postępu 21B
02-676 Warsaw
Temmler Pharma GmbH
Temmlerstraße 2
35039 Marburg
Germany
Valpharma International S.p.A.
Via G. Morgagni, 2
47864 Pennabilli (RN)
Italy
marketing authorization holder:
Viatris Healthcare Sp. z o.o.
ul. Postępu 21B
02-676 Warsaw
tel. 22 546 64 00
Date of last revision of the leaflet:06/2025
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.